An Italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
MP-AA-1
Matricellular protein ligand
The antigen recognized by monoclonal antibody MP-AA-1 is a secreted protein which plays an important role in cell-cell and cell extra-cellular matrix adhesion and invasion in many cancers.
MediaPharma has shown that MP-AA-1 is an effective inhibitor of tumor growth in vivo.
MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
